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Abstract.  A  monoclonal antibody (mAB 1C4C10) that 
reacts specifically with human nuclear proteins IEF 
8Z30 and 8Z31  (charge variants;  HeLa protein cata- 
logue number;  Bravo, R., and J.  E.  Celis,  1982,  Clin. 
Chem., 28:766-781)  has been microinjected into the 
cytoplasm of cultured cells that either express (pri- 
mates) or lack these proteins (at least having similar 
molecular weights and pls; other species), and its cel- 
lular localization has been determined by indirect im- 
munofluorescence. Nuclear localization (nucleolar and 
nucleoplasmic) of the antibody was observed only in 
cells expressing these antigens,  suggesting that a deter- 
minant present in IEF 8Z30 and 8Z31  is required for 
cytoplasm-nuclear translocation.  Nuclear migration 
was not inhibited by cycloheximide, implying that 
these proteins may shuttle between nucleus and 
cytoplasm. The results assumed to support the signal 
rather than the free diffusion model are further sup- 
ported by microinjection experiments using antibodies 
(proliferating cell nuclear antigen/cyclin,  DNA) that 
react with nuclear components but do not recognize 
cytoplasmic antigens.  Furthermore,  they raise the pos- 
sibility that some nonnuclear proteins may be trans- 
ported to the nucleus by interacting  with proteins har- 
boring nuclear location signals. 
T 
wo models have been proposed to account for the 
specific localization  of nuclear proteins.  The first as- 
sumes that proteins diffuse freely into the nucleus (al- 
beit at different rates),  but only some are retained  because 
of their affinity to a nondiffusible  nuclear component (2, 3, 
22). The second model, which applies particularly  to larger 
proteins,  assumes that certain proteins are selectively trans- 
located  across the  nuclear  membrane  (12-14).  The  latter 
model implies the presence of a signal in a nuclear protein 
that identifies  it as a component destined for the nucleus. 
Even though there is now abundant evidence that supports 
the signal model (at least for large proteins;  15-18, 23-26), 
a recent report by Bennett et al. (1) suggested that large pro- 
teins such as IgG molecules (C23 antibodies)  can enter the 
nucleus  when  microinjected  by  the  erythrocyte-mediated 
microinjection.  Since nuclear entry was not inhibited by cy- 
cloheximide,  it was concluded that antibodies penetrate the 
nuclear membrane (limited  rate of entry) and bind nuclear 
proteins  (C23)  with the affinity characteristic  of antibody- 
antigen  reactions. 
Here we present experiments  in which we have microin- 
jected a monoclonal antibody (mAB 1C4C10) that reacts spe- 
cifically  with nuclear proteins IEF 8Z30 and 8Z31 (charge 
variants;  HeLa protein catalogue number [4]) (10) into the 
cytoplasm of cells that either express (primates) or lack these 
proteins  (at least having  similar  molecular weights or pls; 
other species) (10). The results,  which are similar  to those 
reported by Bennett et al. (1), are interpreted however to sup- 
port the signal model. This conclusion is further supported 
by microinjection  experiments  involving  proliferating  cell 
nuclear antigen  (PCNA)l/cyclin  and DNA antibodies. 
Materials and Methods 
Cells 
All cultured cells used in this study were grown in Dulbecco's modified Ea- 
gle's medium containing 10 % fetal calf serum and antibiotics (100 U/ml pen- 
icillin,  50 I.tg/ml streptomycin). The SV-40  transformed human keratino- 
cytes (KI4) were a kind gift of E. B. Lane of the Imperial Cancer Research 
Laboratories. 
Antibodies 
The preparation of mouse mAB 1C4C10 (IgG) has been described in detail 
elsewhere (10). Specificity data are given in the Results section. The Ig frac- 
tion  was purified  from ascites fluid by  ammonium sulfate precipitation 
(50%)  followed by dialysis of the redissolved precipitate  against Hanks' 
buffered saline. Human PCNA antibodies (IgG) specific for cyclin (11) were 
a kind girl from E. Tan. Human anti-DNA autoantibodies (IgG) were ob- 
tained from the Aarhus Kommune Hospital. lmmunofluorescence staining 
with this antibody was abolished by DNase I treatment of the monolayers. 
Microinjection of  Somatic Cells with Glass Capillaries 
Microinjection of cultured cells grown attached to glass coverslips was car- 
ried out essentially as described by Celis (8). Approximately 30 cells were 
injected  per experiment and each experiment was repeated  at  least five 
times. Viability was higher than 90%. 
1.  Abbreviation  used in  this paper:  PCNA, proliferating cell  nuclear an- 
tigen. 
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The Journal of Cell Biology, Volume 103 (No. 6, Pt.  1), Dec. 1986  2083-2089  2083 Figure 1. Localization of microinjected mAB 1C4C10. Antibodies were microinjected (direct microinjection) into the cytoplasm of human 
KI4 cells and subsequently localized by immunofluorescence at 1 (A), 2% (B), and 18 h (C), respectively. (D) Fluorescence micrograph 
of K14 cells fixed with methanol and reacted with mAB 1C4C10. Bar, 10 p.m. 
Other Procedures 
The procedures for labeling cells  with  [3SS]methionine  (5),  two-dimen- 
sional gel electrophoresis (7), and indirect immunofluorescence (21) have 
been described in detail elsewhere. 
Results 
Nuclear Migration of  mAB 1C4C10 after 
Cytoplasmic Microinjection of  Cultured Cells 
Expressing Its Antigens 
Fig.  1  shows  immunofluorescence micrographs  of SV-40 
transformed human keratinocytes (K14 cells) microinjected 
into  the  cytoplasm  with  a  monoclonal  antibody  (mAB 
1C4C10) that reacts specifically with nuclear proteins IEFs 
8Z30 and 8Z31  (Fig. 2,  see also Fig.  3 A) (10). Cells were 
processed for immunofluorescence at 1 (Fig.  1 A), 2 V2 (Fig. 
1 B), and 18 h (Fig.  1 C) after microinjection. Cytoplasmic 
localization of the antibody was observed during the first 
hour  after  injection,  but  a  distinct  nuclear  localization 
(nucleolar and nucleoplasmic) was detected as early as 21A 
h.  Thereafter, there was  increasing nuclear migration (not 
shown) and at 18 h most of the antibody was localized in the 
nucleus (Fig.  1 C),  revealing a  fluorescence pattern very 
similar to that observed in methanol-fixed K14 cells reacted 
with mAB IC4C10 (Fig.  1 D). Similar results were obtained 
with African green monkey kidney cultured cells (BS-C-1) 
injected under comparable conditions (Fig. 4 A, 1 h after in- 
jection; Fig. 4 B,  19 h after injection). These cells express 
both IEF 8Z30 and 8Z31 as determined by two-dimensional 
gel electrophoresis (Fig.  3 B). 
Cytoplasmic Localization of  mAB 1C4C10 after 
Microinjection of  Cultured Cells Lacking Its Antigens 
In  contrast  to  the  above  results,  microinjection of mAB 
1C4C10 into the cytoplasm of cultured cells that do not ex- 
press proteins having similar molecular weights or PIs as hu- 
man or monkey IEFs 8Z30 and 8Z31 (Figs. 3, C-F) did not 
result in nuclear migration even after prolonged periods of 
time. Fig. 5, A-D shows immunofluorescence micrographs 
of dog (dog thymus, Fig.  5 A), goat (goat synovial, Fig.  5 
B), mink (mink lung, Fig. 5 C), and mouse (3T3, Fig. 5 D) 
cultured cells injected with mAB 1C4C10 and processed for 
immunofluorescence 23  h  after  injection.  Representative 
two-dimensional gels  (isoelectric focusing,  only the perti- 
nent area  of the  gel  is  shown) of [35S]methionine-labeled 
proteins from these cells are shown in Fig. 3, C-F, respec- 
tively.  Furthermore,  one-dimensional  gel  immunoblots of 
proteins  extracted  from these  cells  showed  no  detectable 
The Journal  of Cell  Biology,  Volume 103, 1986  2084 Figure 2. Identification of the antigens reacting with mAB 1C4C10 by two-dimensional gel electrophoresis and immunobiotting. K14 cell 
proteins were separated by two-dimensional gel electrophoresis (isoelectric focusing, non-equilibrium pH gradient electrophoresis) and 
transferred to nitrocellulose sheets. Antigens were identified by superposition of immunoblots with their corresponding (identical) autora- 
diograms. 
reaction with mAB 1C4C10 (Fig. 6, lanes B-D; control K14 
and  BSC-1  extracts are  shown  in  lanes A  and  E,  respec- 
tively). 
Antibodies Do Not Enter the Nucleus by 
Free Diffusion 
Even though the experiments presented above suggested that 
mAB 1C4C10 may be transported to the nucleus by interact- 
ing with its antigens, the possibility could not be eliminated 
that it penetrated the nuclear envelope by diffusion. To ap- 
proach this question we carried out microinjection experi- 
ments using antibodies that react with nuclear components 
but do not recognize cytoplasmic antigens. PCNA/CYclin an- 
tibodies (20) react specifically with S-phase nuclear cyclin 
(Fig. 7 A) (6, 9,  11,  19) but do not recognize newly synthe- 
sized cytoplasmic cyclin (11). Accordingly, if these antibodies 
enter the nucleus by diffusion they should be retained by in- 
teracting  with  nondiffusible cyclin present  in  the  S-phase 
cells (40% of the cell population, see also Fig. 7 A). Fig. 7, 
B and C shows double-immunofluorescence micrographs of 
asynchronous  K14  cells  microinjected  with  a  mixture  of 
PCNA/cyclin antibodies (Fig. 7 B) and mAB 1C4C10 (Fig. 
7 C). Of 40 injected cells analyzed in this particular experi- 
ment, none showed nuclear localization of the PCNA/CYclin 
antibodies (Fig. 7 B), while all cells showed nuclear local- 
ization of mAB  1C4C10 (Fig.  7  C).  In line with the above 
observations,  cytoplasmic microinjection of asynchronous 
K14 cells with DNA antibodies that react only with nuclear 
DNA (Fig.  8 A) also failed to reveal nuclear accumulation 
of the immune IgG molecules even after prolonged periods 
of time (Fig.  8 B). 
Nuclear Migration of  mAB 1C4C10 in Human K14 Cells 
Is Not Inhibited by Cycloheximide 
Treatment of human  K14  cells  with  cycloheximide under 
conditions in which >95 % of protein synthesis was inhibited 
(10 I.tg/ml given 2 h before injection and kept in the medium 
for 23 h after injection) did not inhibit nuclear accumulation 
of mAB 1C1410 (Fig. 9), indicating that protein synthesis in 
general and in particular newly synthesized IEFs 8Z30 and 
8Z31  are  not  required  for nuclear  localization of the  an- 
tibody. 
Cytoplasmic microinjection of cultured cells of nonpri- 
mate origin in the presence of cycloheximide did not result 
in nuclear migration of the antibody (data not shown). 
Discussion 
We have shown that mAB 1C4C10 accumulates in the nucleus 
when injected into the cytoplasm of cultured cells expressing 
its antigens, the nuclear proteins IEF 8Z30 and 8Z31 (4, 10). 
Nuclear  accumulation  was  not  observed  in  cells  lacking 
these proteins (at least having similar molecular weights and 
pls), suggesting that a determinant present in IEF 8Z30 and 
Madsen et al. Microinjection of Antibodies  2085 Figure 3. Two-dimensional gel electrophoresis (isoelectric focusing) of [35S]methionine-labeIed  proteins from: (A) K14, (B) BS-C-1, (C) 
dog thymus, (D) goat synovial membrane, (E) mink lung, and (F) mouse 3T3 cells. Only the pertinent area of the gel is shown. Actin 
and alpha- and beta-tubulin (ut, I~t) are indicated for reference. 
8Z31 may be required for cytoplasm-nuclear translocation. 
Furthermore, nuclear migration was not inhibited by cyclo- 
heximide, implying that these proteins may shuttle between 
nucleus and cytoplasm. 
Similar results to those described here have been reported 
by  Bennett et  al.  (1)  who  injected antibodies  against  the 
nucleolar protein C23 using the erythrocyte-mediated  micro- 
injection. Since nuclear entry was not inhibited by cyclohex- 
imide, they concluded that the antibodies penetrated the nu- 
cleus  by  diffusion  and  remained  there  because  of their 
interaction with  a  nondiffusible nuclear component,  most 
likely protein C23.  Our results, however, using two antibod- 
ies (PCNA/cyclin, DNA) that react with nuclear components 
but do not  recognize cytoplasmic antigens,  clearly argue 
against the diffusion model as we did not observe nuclear lo- 
calization of  the immune IgG molecules even after prolonged 
Figure  5.  Localization of mAB 1C4C10 microinjected into cultured cells of nonprimate origin. (A) Dog thymus, (B) goat synovial, (C) 
mink lung, and (D) mouse 3T3 cells~ Cells were processed for immunofluorescence 18 h after microinjection. Bar,  10 Ixm. 
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clear antigens (Figs. 7 A and 8 A), and therefore, it was ex- 
pected that if immune IgG molecules penetrated the nuclear 
envelope by diffusion at least some cells should have ex- 
hibited nuclear fluorescence. These results strengthen the 
notion that mAB 1C4C10 enters the nucleus by combining 
with its antigens (signal model) rather than by diffusion. Re- 
cently, Tsuneoka et al. (26) have presented evidence showing 
that anti-HMG-1 antibodies migrate into the nucleus when 
co-introduced with HMG-1  into the cytoplasm of F1 cells. 
No nuclear migration was observed when the antibody alone 
was injected into the cytoplasm. 
Finally, our results raise the interesting possibility that 
some non-nuclear proteins may be transported to the nucleus 
by interacting with nuclear proteins harboring location sig- 
nals.  Further experiments will be necessary to assess this 
possibility. 
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Figure  4.  Localization of mAB  IC4C10 microinjected into the 
cytoplasm of monkey BS-C-1 cells. (A) 1 h after injection (B) 19 h 
after injection. Bar, 10 Itm. 
Madsen et al. Microinjection of Antibodies  2087 Figure 6. One-dimensional immunoblot analysis (mAB 1C4C10) of 
proteins extracted from (A) K14, (B) dog thymus, (C) goat synovial, 
(D)  mink lung,  and  (E)  BS-C-1  cells. 
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